. La-méthode-de-spectrométrie-et-la-méthode-picogreen, sont basées sur d'absorption UV Plusieurs facteurs peut-être déranger l'absorption pendant la quantification de l'ADN circulant dans le sérum. En outre, notre échantillonnage est faible. Nos résultats ne permettent pas de considérer le taux d'ADN circulant dans le sérum comme un moyen de diagnostic du CCR, La quantification de l'ADN circulant dans le sérum par une autre méthode (par exemple, real-time PCR) est nécessaire pour confirmer nos résultats

A. Altimari, A. Grigioni, E. Benedettini, E. Gabusi, R. Schiavina et al., Diagnostic Role of Circulating Free Plasma DNA Detection in Patients With Localized Prostate Cancer, American Journal of Clinical Pathology, vol.129, issue.5

P. Anker, M. Stroun, and P. Maurice, Spontaneous release of DNA by human blood lymphocytes a shown in an in vitro system, Cancer Res, vol.35, pp.2375-2382, 1975.

W. Ayala, L. Moore, and E. Hess, THE PURPLE COLOR REACTION GIVEN BY DIPHENYLAMINE REAGENT. I. WITH NORMAL AND RHEUMATIC FEVER SERA 1, Journal of Clinical Investigation, vol.30, issue.7, pp.781-785, 1951.
DOI : 10.1172/JCI102492

M. Badger and G. Price, The Role of Carbonic Anhydrase in Photosynthesis, Annual Review of Plant Physiology and Plant Molecular Biology, vol.45, issue.1
DOI : 10.1146/annurev.pp.45.060194.002101

B. Bassil, D. Dosoretz, G. Prout, and . Jr, Validation of the tumor, nodes and metastasis classification of renal cell carcinoma, J Urol, vol.134, pp.450-454, 1985.

E. Quoix and P. Oudet, Plasma DNA microsatellite panel as sensitive and tumor-specific marker in lung cancer Patients, Int J Cancer, vol.105, pp.361-370, 2003.

M. Blinov, I. Luganova, and A. Vladimirova, Factors of nucleic nature in human blood plasma, Vopr Med Khim, vol.27, pp.600-603, 1981.

J. Boddy, S. Gal, P. Malone, A. Harris, and J. Wainscoat, Prospective Study of Quantitation of Plasma DNA Levels in the Diagnosis of Malignant versus Benign Prostate Disease, Clinical Cancer Research, vol.11, issue.4, pp.1394-1399, 2005.
DOI : 10.1158/1078-0432.CCR-04-1237

H. Brauch, G. Weirich, J. Brieger, D. Glavac, H. Rödl et al., VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation, Cancer Res, vol.60, pp.1942-1948, 2000.

X. Chen, H. Bonnefoi, M. Pelte, J. Lyautey, C. Lederrey et al., Telomerase RNA as a detection marker in the serum of breast cancer patients, Clin Cancer Res, vol.6, pp.3823-3826, 2000.

X. Chen, H. Bonnefoi, S. Diebold-berger, J. Lyautey, C. Lederrey et al., Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer, Clin Cancer Res, vol.5, pp.2297-2303, 1999.

H. Cohen and F. Mcgovern, Renal-Cell Carcinoma, New England Journal of Medicine, vol.353, issue.23, 2005.
DOI : 10.1056/NEJMra043172

C. Coulange and J. Davin, Urologie et cancer. Paris, 2004.

F. Dasi, S. Lledo, E. Garcia-granero, R. Ripoll, M. Marugan et al., Real-Time Quantification in Plasma of Human Telomerase Reverse Transcriptase (hTERT) mRNA: A Simple Blood Test to Monitor Disease in Cancer Patients, Laboratory Investigation, vol.47, issue.5, pp.767-769, 2001.
DOI : 10.1073/pnas.96.25.14276

L. Davis and J. Davis, Detection of circulating dna by counterimmunoelectrophoresis (cie), Arthritis & Rheumatism, vol.200, issue.1, pp.52-58, 1973.
DOI : 10.1002/art.1780160108

W. De-riese, W. Crabtree, E. Allhoff, M. Werner, S. Liedke et al., Prognostic significance of Ki-67 immunostaining in nonmetastatic renal cell carcinoma., Journal of Clinical Oncology, vol.11, issue.9, pp.1804-1808, 1993.
DOI : 10.1200/JCO.1993.11.9.1804

J. Eble, G. Sauter, J. Epstein, and I. Sesterhenn, Pathology and genetics of tumours of the urinary system and male genital organs, 2004.

P. Bastian, Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer, J Urol, vol.181, pp.363-371, 2009.

J. Ferlay, P. Autier, M. Boniol, M. Heanue, M. Colombet et al., Estimates of the cancer incidence and mortality in Europe in 2006, Annals of Oncology, vol.18, issue.3, pp.581-592, 2006.
DOI : 10.1093/annonc/mdl498

A. Foss, M. Guille, N. Occleston, P. Hykin, J. Hungerford et al., The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction, British Journal of Cancer, vol.72, issue.1, pp.155-159, 1995.
DOI : 10.1038/bjc.1995.293

G. Fournie, J. Courtin, and F. Laval, Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours, Cancer Letters, vol.91, issue.2, pp.221-227, 1995.
DOI : 10.1016/0304-3835(95)03742-F

S. Fuhrman and L. Lasky, Prognostic significance of morphologic parameters in renal cell carcinoma, The American Journal of Surgical Pathology, vol.6, issue.7, pp.655-663, 1982.
DOI : 10.1097/00000478-198210000-00007

Y. Fujiwara, D. Chi, H. Wang, P. Keleman, D. Morton et al., Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients, Cancer Res, vol.59, pp.1567-1571, 1999.

M. Giacona, G. Ruben, K. Iczkowski, T. Roos, D. Porter et al., Cell-Free DNA in Human Blood Plasma, Pancreas, vol.17, issue.1, pp.89-97, 1998.
DOI : 10.1097/00006676-199807000-00012

J. Gnarra, K. Tory, Y. Weng, L. Schmidt, M. Wei et al., Mutations of the VHL tumour suppressor gene in renal carcinoma, Nature Genetics, vol.88, issue.1, pp.85-90, 1994.
DOI : 10.1038/ng0594-85

K. Grabmaier, A. De-weijert, M. Verhaegh, G. Schalken, J. Oosterwijk et al., Strict regulation of CAIX (G250/MN) by HIF-1alpha in clear cell renal cell carcinoma

H. Gross, B. Verwer, D. Houck, R. Hoffman, and D. Recktenwald, Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10(-7)., Proceedings of the National Academy of Sciences, vol.92, issue.2, pp.537-541, 1995.
DOI : 10.1073/pnas.92.2.537

R. Hanley, K. Rieger-christ, D. Canes, N. Emara, A. Shuber et al., DNA Integrity Assay: A Plasma-Based Screening Tool for the Detection of Prostate Cancer, Clinical Cancer Research, vol.12, issue.15, pp.4569-4574, 2006.
DOI : 10.1158/1078-0432.CCR-06-0130

D. Hasselmann, G. Rappl, M. Rössler, S. Ugurel, W. Tilgen et al., Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma., Oncology Reports, vol.8, pp.115-118, 2001.
DOI : 10.3892/or.8.1.115

G. Hughes, S. Cohen, R. Lightfoot, . Jr, J. Meltzer et al., The Release of DNA into Serum and Synovial Fluid, Arthritis & Rheumatism, vol.166, issue.2, pp.259-266, 1971.
DOI : 10.1002/art.1780140211

M. Ivan, K. Kondo, H. Yang, W. Kim, J. Valiando et al., HIFalpha Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing, Science, vol.292, issue.5516, pp.464-468, 2001.
DOI : 10.1126/science.1059817

M. Merrill, M. Proescholdt, E. Oldfield, J. Lee, J. Zavada et al., Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer, Am J Pathol, vol.158, pp.905-919, 2001.

A. Jaff, V. Molinié, F. Mellot, A. Guth, T. Lebret et al., Evaluation of imaging-guided fine-needle percutaneous biopsy of renal masses, European Radiology, vol.13, issue.3, pp.1721-1726, 2005.
DOI : 10.1007/s00330-004-2577-9

A. Jemal, T. Murray, E. Ward, A. Samuels, R. Tiwari et al., Cancer Statistics, 2005, CA: A Cancer Journal for Clinicians, vol.55, issue.1, pp.10-30, 2005.
DOI : 10.3322/canjclin.55.1.10

Z. Jin, Deiry WS Overview of cell death signaling pathways, Cancer Biol Ther, vol.4, pp.139-163, 2005.

R. Kamm and A. Smith, Ribonuclease activity in human plasma, Clinical Biochemistry, vol.5, issue.1-4, pp.198-200, 1972.
DOI : 10.1016/S0009-9120(72)80033-X

R. Kamm and A. Smith, Nucleic acid concentrations in normal human plasma, Clin Chem, vol.18, pp.519-522, 1972.

A. Katagiri, R. Watanabe, and Y. Tomita, E-cadherin expression in renal cell cancer and its significance in metastasis and survival, British Journal of Cancer, vol.71, issue.2, pp.376-379, 1995.
DOI : 10.1038/bjc.1995.76

V. Kaznacheev and Y. Polyakov, A study of some indices of nucleic acid metabolism in patients with atherosclerosis, Kardiologiya, vol.7, pp.22-25, 1967.

K. Kobayashi, N. Sakai, S. Kaneko, S. Kawakami, M. Baba et al., Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinico-pathological parameters, Genes Chromosomes Cancer, vol.34, pp.58-68, 2002.

M. Kopreski, F. Benko, L. Kwak, and C. Gocke, Detection of tumor messenger RNA in the serum of patients with malignant melanoma, Clin Cancer Res, vol.5, 1999.

N. Lam, T. Rainer, L. Chan, G. Joynt, and Y. Lo, Time Course of Early and Late Changes in Plasma DNA in Trauma Patients, Clinical Chemistry, vol.49, issue.8, pp.1286-1291, 2003.
DOI : 10.1373/49.8.1286

W. Modi and L. Geil, Identification of the von Hippel-Lindau disease tumor suppressor gene, Science, vol.260, pp.1317-1320, 1993.

J. Lee, Compounds interfering in the Diphenylamine Test for Deoxyribonucleic Acid, Nature, vol.14, issue.4903, pp.264-266, 1963.
DOI : 10.1084/jem.72.2.139

S. Leon, A. Green, M. Yaros, and B. Shapiro, Radioimmunoassay for nanogram quantities of DNA, Journal of Immunological Methods, vol.9, issue.2, pp.157-164, 1975.
DOI : 10.1016/0022-1759(75)90106-4

H. Leslie and C. Sobin, UICC, in TNM Classification of Malignant Tumors, 6 th edition, Wittekind International Union Against Cancer, 2002.

C. Li, H. Hsu, T. Wu, K. Tsao, C. Sun et al., Cell-free DNA is released from tumor cells upon cell death: A study of tissue cultures of tumor cell lines, Journal of Clinical Laboratory Analysis, vol.321, issue.4, pp.103-107, 2003.
DOI : 10.1002/jcla.10081

C. Genin and J. Tostain, Rapid and sensitive detection of messenger RNA expression for molecular differential diagnosis of renal cell carcinoma, Clin Cancer Res, vol.9, pp.6441-6446, 2003.

G. Li, M. Cuilleron, M. Cottier, A. Gentil-perret, C. Lambert et al., The Use of MN/CA9 Gene Expression in Identifying Malignant Solid Renal Tumors, European Urology, vol.49, issue.2, pp.401-405, 2006.
DOI : 10.1016/j.eururo.2005.10.025

G. Li, M. Cuilleron, A. Gentil-perret, and J. Tostain, Characteristics of image-detected solid renal masses: Implication for optimal treatment, International Journal of Urology, vol.75, issue.2, pp.63-67, 2004.
DOI : 10.1016/S0090-4295(02)01501-7

G. Li, G. Feng, A. Gentil-perret, C. Genin, and J. Tostain, CA9 gene expression in conventional renal cell carcinoma: a potential marker for prediction of early metastasis after nephrectomy, Clinical & Experimental Metastasis, vol.64, issue.3, pp.149-155, 2007.
DOI : 10.1007/s10585-007-9064-z

G. Li, A. Gentil-perret, C. Lambert, C. Genin, and J. Tostain, S100A1 and KIT gene expressions in common subtypes of renal tumours, European Journal of Surgical Oncology (EJSO), vol.31, issue.3, pp.299-303, 2005.
DOI : 10.1016/j.ejso.2004.11.009

J. Mosnier, C. Genin, and J. Tostain, The expression of G250/mn/CA9 antigen by flow cytometry: its possible implication for detection of micrometastatic renal cancer cells

J. Mckiernan, R. Buttyan, N. Bander, M. Stifelman, A. Katz et al., Expression of the tumor-associated gene MN: a potential biomarker for human renal cell carcinoma, Cancer Res, vol.57, pp.2362-2365, 1997.

P. Mandel and P. Metais, Les acides nucleiques du plasma sanguin chez l'homme

S. Mandriota, K. Turner, D. Davies, P. Murray, N. Morgan et al., HIF activation identifies early lesions in VHL kidneys, Cancer Cell, vol.1, issue.5, pp.459-468, 2002.
DOI : 10.1016/S1535-6108(02)00071-5

V. Margulis, P. Tamboli, S. Matin, M. Meisner, D. Swanson et al., Redefining pT3 renal cell carcinoma in the modern era, Cancer, vol.173, issue.12, pp.2439-2444, 2007.
DOI : 10.1002/cncr.22713

L. Mattano, . Jr, T. Moss, and S. Emerson, Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptasepolymerase chain reaction, Cancer Res, vol.52, pp.4701-4705, 1992.

N. Meldrum and F. Roughton, The state of carbon dioxide in blood, The Journal of Physiology, vol.80, issue.2, pp.143-170, 1933.
DOI : 10.1113/jphysiol.1933.sp003078

H. Moch, . Schraml-p, L. Bubendorf, M. Mirlacher, J. Kononen et al., High-Throughput Tissue Microarray Analysis to Evaluate Genes Uncovered by cDNA Microarray Screening in Renal Cell Carcinoma, The American Journal of Pathology, vol.154, issue.4, pp.981-986, 1999.
DOI : 10.1016/S0002-9440(10)65349-7

T. Moss and D. Sanders, Detection of neuroblastoma cells in blood., Journal of Clinical Oncology, vol.8, issue.4, pp.736-740, 1990.
DOI : 10.1200/JCO.1990.8.4.736

Y. Murakami, K. Kanda, M. Tsuji, H. Kanayama, and K. S. Mn, MN/CA9 gene expression as a potential biomarker in renal cell carcinoma, BJU International, vol.159, issue.7, pp.743-747, 1999.
DOI : 10.1046/j.1464-410x.1999.00007.x

P. Johnson and Y. Lo, Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals, Clin Chem, vol.48, pp.1212-1217, 2002.

M. Ohh, R. Yauch, K. Lonergan, J. Whaley, A. Stemmer-rachamimov et al., The von Hippel-Lindau Tumor Suppressor Protein Is Required for Proper Assembly of an Extracellular Fibronectin Matrix, Molecular Cell, vol.1, issue.7, pp.959-968, 1998.
DOI : 10.1016/S1097-2765(00)80096-9

C. Pan, P. Chen, and H. Chiang, Overexpression of KIT (CD117) in Chromophobe Renal Cell Carcinoma and Renal Oncocytoma, American Journal of Clinical Pathology, vol.121, issue.6, pp.878-883, 2004.

A. Pantuck, G. Zeng, A. Belldegrun, and R. Figlin, Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway

V. Paradis, S. Ferlicot, E. Ghannam, L. Zeimoura, P. Blanchet et al., CD44 IS AN INDEPENDENT PROGNOSTIC FACTOR IN CONVENTIONAL RENAL CELL CARCINOMAS, The Journal of Urology, vol.161, issue.6, pp.1984-1987, 1999.
DOI : 10.1016/S0022-5347(05)68869-6

. Plasma, Serum of Lung Cancer Patients as a Potential Screening and Prognostic Tool

K. Roszkowski and J. Chorostowska-wynimko, Evaluation of fluorescence-based methods for total vs. amplifiable DNA quantification in plasma of lung cancer patients

Y. Ueda and E. Otsuji, Quantification of plasma cell-free DNA in patients with gastric cancer, Anticancer Res, vol.27, pp.2747-2751, 2007.

C. Schofield and P. Ratcliffe, Oxygen sensing by HIF hydroxylases, Nature Reviews Molecular Cell Biology, vol.5, issue.5, pp.343-354, 2004.
DOI : 10.1038/nrm1366

H. Schwarzenbach, J. Stoehlmacher, K. Pantel, and E. Goekkurt, Detection and Monitoring of Cell-Free DNA in Blood of Patients with Colorectal Cancer, Annals of the New York Academy of Sciences, vol.5, issue.1, pp.190-196, 2008.
DOI : 10.1196/annals.1448.025

G. Semenza, Hypoxia, Clonal Selection, and the Role of HIF-1 in Tumor Progression, Critical Reviews in Biochemistry and Molecular Biology, vol.59, issue.2
DOI : 10.1074/jbc.271.46.29483

K. Sisco, Is RNA in serum bound to nucleoprotein complexes?, Clin Chem, vol.47, pp.1744-1745, 2001.

W. Siow, S. Yip, L. Ng, P. Tan, W. Cheng et al., Renal cell carcinoma: incidental detection and pathological staging, J R Coll Surg Edinb, vol.45, pp.291-295, 2000.

S. Skates and O. Iliopoulos, Molecular Markers for Early Detection of Renal Carcinoma: Investigative Approach, Clinical Cancer Research, vol.10, issue.18, pp.6296-6301, 2004.
DOI : 10.1158/1078-0432.CCR-050010

A. Skolarikos, G. Alivizatos, P. Laguna, and J. De-la-rosette, A Review on Follow-Up Strategies for Renal Cell Carcinoma after Nephrectomy, European Urology, vol.51, issue.6, pp.1490-1497, 2007.
DOI : 10.1016/j.eururo.2006.12.031

K. Smith, C. Jakubzick, T. Whittam, and J. Ferry, Carbonic anhydrase is an ancient enzyme widespread in prokaryotes, Proceedings of the National Academy of Sciences, vol.96, issue.26, 1999.
DOI : 10.1073/pnas.96.26.15184

G. Sorenson, D. Porter, and R. Barth, Detection of mutated KRAS2 sequences in plasma from patients with pancreatic carcinoma in comparison with the CA19-9 assay

M. Bellomi, G. Pelosi, M. Pierotti, and U. Pastorino, Quantification of free circulating DNA as a diagnostic marker in lung cancer, J Clin Oncol, vol.21, pp.3902-3908, 2003.

C. Steinman, Use of nucleic acid hybridization for specific detectionof submicrogram quantities of DNA, and its application to human plasma, Clin Chem, vol.21, pp.407-411, 1975.

C. Steinman, Circulating dna in polyarteritis nodosa and related syndromes, Arthritis & Rheumatism, vol.118, issue.12
DOI : 10.1002/art.1780251206

C. Steinman, Circulating DNA in systemic lupus erythematosus. Isolation and characterization., Journal of Clinical Investigation, vol.73, issue.3, pp.832-841, 1984.
DOI : 10.1172/JCI111278

S. Störkel, J. Eble, K. Adlakha, M. Amin, M. Blute et al., Classification of renal cell carcinoma

M. Stroun, P. Anker, M. P. Gahan, and P. , Circulating Nucleic Acids in Higher Organisms, Int Rev Cytol, vol.51, pp.1-48, 1977.
DOI : 10.1016/S0074-7696(08)60225-9

K. Su and D. Pisetsky, The Role of Extracellular DNA in Autoimmunity in SLE, Scandinavian Journal of Immunology, vol.64, issue.3, pp.175-183, 2009.
DOI : 10.1111/j.1365-3083.2009.02300.x

N. Tsui, E. Ng, and Y. Lo, Stability of endogenous and added RNA in blood specimens, serum, and plasma, Clin Chem, vol.48, pp.1647-1653, 2002.

A. Vasudevan, R. Davies, B. Shannon, and R. Cohen, Incidental renal tumours: the frequency of benign lesions and the role of preoperative core biopsy, BJU International, vol.197, issue.5, pp.946-949, 2006.
DOI : 10.1097/01.ju.0000102409.69570.f5

P. Vaupel, D. Kelleher, and M. Hockel, Oxygenation status of malignant tumors: Pathogenesis of hypoxia and significance for tumor therapy, Seminars in Oncology, vol.28, pp.29-35, 2001.
DOI : 10.1016/S0093-7754(01)90210-6

G. Wang and G. Semenza, Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia, J Biol Chem, vol.268, pp.21513-21518, 1993.

K. Eckardt, Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas

C. Wykoff, N. Beasley, P. Watson, K. Turner, J. Pastorek et al., Hypoxiainducible expression of tumor-associated carbonic anhydrases, Cancer Res, vol.60, pp.7075-7083, 2000.

C. Wykoff, C. Pugh, P. Maxwell, A. Harris, and P. Ratcliffe, Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling, Oncogene, vol.19, issue.54, pp.6297-6305, 200014.
DOI : 10.1038/sj.onc.1204012

A. Wyllie and . Glucocorticoid, Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation, Nature, vol.62, issue.5756, pp.555-556, 1980.
DOI : 10.1038/284555a0

G. Xie, A. Hou, L. Li, Y. Gao, and S. Cheng, Quantification of plasma DNA as a screening tool for lung cancer, Chin Med J, vol.117, pp.1485-1488, 2004.

M. Yao, M. Yoshida, T. Kishida, N. Nakaigawa, M. Baba et al., VHL Tumor Suppressor Gene Alterations Associated With Good Prognosis in Sporadic Clear-Cell Renal Carcinoma, CancerSpectrum Knowledge Environment, vol.94, issue.20, pp.1569-1575, 2002.
DOI : 10.1093/jnci/94.20.1569

R. Zachariah, S. Schmid, N. Buerki, R. Radpour, W. Holzgreve et al., Levels of Circulating Cell-Free Nuclear and Mitochondrial DNA in Benign and Malignant Ovarian Tumors, Obstetrics & Gynecology, vol.112, issue.4, pp.843-850, 2008.
DOI : 10.1097/AOG.0b013e3181867bc0